These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 33583159

  • 1. C-X-C chemokine receptor 2 (Cxcr2) promotes hepatocellular carcinoma immune evasion via regulating programmed death-ligand 1 (PD-L1).
    Wan Y, Ge K, Zhou W, Lu J, Jia C, Zhu H.
    Biol Chem; 2021 May 26; 402(6):729-737. PubMed ID: 33583159
    [Abstract] [Full Text] [Related]

  • 2. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J, Zhang N, Sun H, Su L, Zhang C, Xu H, Feng J, Wang M, Chen J, Liu L, Shan J, Shen J, Yang Z, Wang G, Zhou H, Prieto J, Ávila MA, Liu C, Qian C.
    Gastroenterology; 2020 Feb 26; 158(3):664-678.e24. PubMed ID: 31678303
    [Abstract] [Full Text] [Related]

  • 3. IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma.
    Zhang W, Liu Y, Yan Z, Yang H, Sun W, Yao Y, Chen Y, Jiang R.
    J Immunother Cancer; 2020 Jun 26; 8(1):. PubMed ID: 32581055
    [Abstract] [Full Text] [Related]

  • 4. TGF-β1-Induced SOX18 Elevation Promotes Hepatocellular Carcinoma Progression and Metastasis Through Transcriptionally Upregulating PD-L1 and CXCL12.
    Chen J, Feng W, Sun M, Huang W, Wang G, Chen X, Yin Y, Chen X, Zhang B, Nie Y, Fan D, Wu K, Xia L.
    Gastroenterology; 2024 Jul 26; 167(2):264-280. PubMed ID: 38417530
    [Abstract] [Full Text] [Related]

  • 5. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade.
    Zhu Y, Yang J, Xu D, Gao XM, Zhang Z, Hsu JL, Li CW, Lim SO, Sheng YY, Zhang Y, Li JH, Luo Q, Zheng Y, Zhao Y, Lu L, Jia HL, Hung MC, Dong QZ, Qin LX.
    Gut; 2019 Sep 26; 68(9):1653-1666. PubMed ID: 30902885
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. KDM1A Promotes Immunosuppression in Hepatocellular Carcinoma by Regulating PD-L1 through Demethylating MEF2D.
    Wang Y, Cao K.
    J Immunol Res; 2021 Sep 26; 2021():9965099. PubMed ID: 34307695
    [Abstract] [Full Text] [Related]

  • 9. FAT10 induces immune suppression by upregulating PD-L1 expression in hepatocellular carcinoma.
    Wang Q, Tan W, Zhang Z, Chen Q, Xie Z, Yang L, Tang C, Zhuang H, Wang B, Jiang J, Ma X, Wang W, Hua Y, Shang C, Chen Y.
    Apoptosis; 2024 Oct 26; 29(9-10):1529-1545. PubMed ID: 38824477
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Exosomal circHIF1A derived from hypoxic-induced carcinoma-associated fibroblasts promotes hepatocellular carcinoma cell malignant phenotypes and immune escape.
    Shang H, Lu L, Fan M, Lu Y, Shi X, Lu H.
    Int Immunopharmacol; 2024 Sep 10; 138():112282. PubMed ID: 38936058
    [Abstract] [Full Text] [Related]

  • 12. Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice.
    Chiu DK, Yuen VW, Cheu JW, Wei LL, Ting V, Fehlings M, Sumatoh H, Nardin A, Newell EW, Ng IO, Yau TC, Wong CM, Wong CC.
    Gastroenterology; 2020 Aug 10; 159(2):609-623. PubMed ID: 32275969
    [Abstract] [Full Text] [Related]

  • 13. Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy.
    Highfill SL, Cui Y, Giles AJ, Smith JP, Zhang H, Morse E, Kaplan RN, Mackall CL.
    Sci Transl Med; 2014 May 21; 6(237):237ra67. PubMed ID: 24848257
    [Abstract] [Full Text] [Related]

  • 14. Glycolytic activation of peritumoral monocytes fosters immune privilege via the PFKFB3-PD-L1 axis in human hepatocellular carcinoma.
    Chen DP, Ning WR, Jiang ZZ, Peng ZP, Zhu LY, Zhuang SM, Kuang DM, Zheng L, Wu Y.
    J Hepatol; 2019 Aug 21; 71(2):333-343. PubMed ID: 31071366
    [Abstract] [Full Text] [Related]

  • 15. Liver fibrosis promotes immune escape in hepatocellular carcinoma via GOLM1-mediated PD-L1 upregulation.
    Ke MY, Xu T, Fang Y, Ye YP, Li ZJ, Ren FG, Lu SY, Zhang XF, Wu RQ, Lv Y, Dong J.
    Cancer Lett; 2021 Aug 10; 513():14-25. PubMed ID: 33992711
    [Abstract] [Full Text] [Related]

  • 16. The polymorphism rs975484 in the protein arginine methyltransferase 1 gene modulates expression of immune checkpoint genes in hepatocellular carcinoma.
    Schonfeld M, Zhao J, Komatz A, Weinman SA, Tikhanovich I.
    J Biol Chem; 2020 May 15; 295(20):7126-7137. PubMed ID: 32245889
    [Abstract] [Full Text] [Related]

  • 17. M1 Macrophages Induce PD-L1 Expression in Hepatocellular Carcinoma Cells Through IL-1β Signaling.
    Zong Z, Zou J, Mao R, Ma C, Li N, Wang J, Wang X, Zhou H, Zhang L, Shi Y.
    Front Immunol; 2019 May 15; 10():1643. PubMed ID: 31379842
    [Abstract] [Full Text] [Related]

  • 18. Effects of liver-targeted drugs on expression of immune-related proteins in hepatocellular carcinoma cells.
    Qiu MJ, He XX, Bi NR, Wang MM, Xiong ZF, Yang SL.
    Clin Chim Acta; 2018 Oct 15; 485():103-105. PubMed ID: 29940148
    [Abstract] [Full Text] [Related]

  • 19. Lenvatinib Targets FGF Receptor 4 to Enhance Antitumor Immune Response of Anti-Programmed Cell Death-1 in HCC.
    Yi C, Chen L, Lin Z, Liu L, Shao W, Zhang R, Lin J, Zhang J, Zhu W, Jia H, Qin L, Lu L, Chen J.
    Hepatology; 2021 Nov 15; 74(5):2544-2560. PubMed ID: 34036623
    [Abstract] [Full Text] [Related]

  • 20. FXa-mediated PAR-2 promotes the efficacy of immunotherapy for hepatocellular carcinoma through immune escape and anoikis resistance by inducing PD-L1 transcription.
    Li X, Gao L, Wang B, Hu J, Yu Y, Gu B, Xiang L, Li X, Li H, Zhang T, Wang Y, Ma C, Dong J, Lu J, Lucas A, Chen H.
    J Immunother Cancer; 2024 Jul 25; 12(7):. PubMed ID: 39060025
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.